Corrigendum to "In vitro evaluation of 2-hydroxyalkylated β-cyclodextrins as potential therapeutic agents for Niemann-pick type C disease" [Mol. Genet. Metab. (2016) 214-219].

scientific article

Corrigendum to "In vitro evaluation of 2-hydroxyalkylated β-cyclodextrins as potential therapeutic agents for Niemann-pick type C disease" [Mol. Genet. Metab. (2016) 214-219]. is …
instance of (P31):
erratumQ1348305
scholarly articleQ13442814

External links are
P356DOI10.1016/J.YMGME.2016.09.004
P698PubMed publication ID27733311

P50authorYuki KondoQ59705484
Yoichi IshitsukaQ73209250
P2093author name stringTomoko Matsumoto
Tetsumi Irie
Kousaku Ohno
Hidetoshi Arima
Keiichi Motoyama
Taishi Higashi
Muneaki Matsuo
Katsumi Higaki
Makiko Taguchi
Hiroko Tokumaru
P433issue3
P921main subjectIn vitro evaluation of 2-hydroxyalkylated β-cyclodextrins as potential therapeutic agents for Niemann-Pick Type C disease.Q51737749
P304page(s)296-297
P577publication date2016-10-10
P1433published inMolecular Genetics and MetabolismQ6895949
P1476titleCorrigendum to "In vitro evaluation of 2-hydroxyalkylated β-cyclodextrins as potential therapeutic agents for Niemann-pick type C disease" [Mol. Genet. Metab. (2016) 214-219]
P478volume120

Reverse relations

Q51737749In vitro evaluation of 2-hydroxyalkylated β-cyclodextrins as potential therapeutic agents for Niemann-Pick Type C disease.corrigendum / erratumP2507

Search more.